$ULTA — AVOID 📊 | 6 MONTHS THESIS

🧭 Conviction: MED Ulta Beauty, Inc. operates as a specialty beauty retailer in the United States, Mexico, and Kuwait. 🎯 FQ1 FY2027 (ends Apr) | reported Jun 02 | Rev $3.2B | Adj EPS $7.74 vs $6.91 🟢 | GAAP op margin 14.2% 💡 The market implies -7.7% FCF growth, reflecting fears of consumer weakness and competitive pressure. However, ULTA's expanding loyalty program and resilience in prestige beauty could deliver stable or growing earnings, surprising to the upside relative to these deeply pessimistic embedded assumptions. 🏢 Business Quality: 7/10 📊 Valuation: fair — trailing P/E 17.6x (above historical median 15.6x but below peak 20.1x); base P/E target of 14.4x yields $459 (below current); reverse DCF... 🔮 Catalyst: Next quarterly earnings (likely September 2026) ⚖️ Avoid — reward/risk unfavorable; stock needs significant growth acceleration to justify upside, while downside is substantial. 📊 Our read: AVOID. Full analysis → https://stockduty.xyz/s/ULTA0711

🧭 Conviction: MED